Business
Vivus Inc. said Tuesday it hired investment banker Credit Suisse First Boston to help it explore options, including selling itself, as the impotence-treatment maker has lost sales to Pfizer Inc.’
Aug. 26, 1998
Technology and the Internet
Vivus Inc. said the group that licensed the patent to it for its impotence drug has dropped a lawsuit alleging Vivus defrauded the group during licensing negotiations.
May 21, 1997
Vivus Inc. said its fourth-quarter profit will fall short of estimates as production delays cut sales of its impotence drug.
Dec. 11, 1997
Vivus Inc. shares fell 19% after new research showed that the company’s impotence treatment, a pellet inserted in the urethra, is less effective than reported in earlier tests.
June 4, 1998
Shares of Vivus Inc., a maker of products for relieving sexual dysfunction, more than doubled Monday amid expectations that the company could revive its flagging fortunes with a new product targeted at women.
March 9, 1999
Vivus Inc. said it will run television ads for its impotence treatment Muse, although NBC rejected the company’s plan to introduce the text-only commercial during the Super Bowl this weekend.
Jan. 21, 1998
Weight-loss drug Qnexa is denied approval
Oct. 29, 2010
The spectacular debut of the impotence drug Viagra helped pharmaceutical giant Pfizer Inc. post a 38% increase in second-quarter profit, the company said Thursday.
July 10, 1998
Science & Medicine
Diet drug Qnexa should be approved, panel says
Feb. 22, 2012